SHH and hepatocellular carcinoma: Furthermore, we have previously generated Shh-KO Hepa1-6 hepatoma and LLC1 Lewis lung carcinoma cells using the CRISPR/Cas9 technology to study whether tumor-derived Shh ligands are the major source of Hh signaling within the TME (19).